151 related articles for article (PubMed ID: 36989283)
1. Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology.
V VR; Ramu A; Chinnappan J; Velmurugan P; Pathak R; Pashameah RA; A Oyouni AA; M Al-Amer O; I Alasseiri M; Hamadi A; A Alanazi M; Sathiamoorthi T
PLoS One; 2023; 18(3):e0282263. PubMed ID: 36989283
[TBL] [Abstract][Full Text] [Related]
2. Understanding the activating mechanism of the immune system against COVID-19 by Traditional Indian Medicine: Network pharmacology approach.
Thirumal Kumar D; Shree Devi MS; Udhaya Kumar S; Sherlin A; Mathew A; Lakshmipriya M; Sathiyarajeswaran P; Gnanasambandan R; Siva R; Magesh R; George Priya Doss C
Adv Protein Chem Struct Biol; 2022; 129():275-379. PubMed ID: 35305722
[TBL] [Abstract][Full Text] [Related]
3. Kabasura Kudineer (KSK), a poly-herbal Siddha medicine, reduced SARS-CoV-2 viral load in asymptomatic COVID-19 individuals as compared to vitamin C and zinc supplementation: findings from a prospective, exploratory, open-labeled, comparative, randomized controlled trial, Tamil Nadu, India.
Natarajan S; Anbarasi C; Sathiyarajeswaran P; Manickam P; Geetha S; Kathiravan R; Prathiba P; Pitchiahkumar M; Parthiban P; Kanakavalli K; Balaji P
Trials; 2021 Sep; 22(1):623. PubMed ID: 34526104
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of Siddha Medicine, Kabasura Kudineer (KSK) compared to Vitamin C & Zinc (CZ) supplementation in the management of asymptomatic COVID-19 cases: A structured summary of a study protocol for a randomised controlled trial.
Natarajan S; Anbarasi C; Sathiyarajeswaran P; Manickam P; Geetha S; Kathiravan R; Prathiba P; Pitchiahkumar M; Parthiban P; Kanakavalli K; Balaji P
Trials; 2020 Oct; 21(1):892. PubMed ID: 33109252
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effect of Kaba Sura Kudineer (AYUSH approved COVID-19 drug)-A Siddha poly-herbal formulation against lipopolysaccharide induced inflammatory response in RAW-264.7 macrophages cells.
Jose SP; M R; S S; Rajan S; Saji S; Narayanan V; S S
J Ethnopharmacol; 2022 Jan; 283():114738. PubMed ID: 34653521
[TBL] [Abstract][Full Text] [Related]
6. Exploring potential mechanisms of Suhexiang Pill against COVID-19 based on network pharmacology and molecular docking.
Li J; Huang Z; Lu S; Luo H; Tan Y; Ye P; Liu X; Wu Z; Wu C; Stalin A; Wang H; Liu Y; Shen L; Fan X; Zhang B; Yi J; Yao L; Xu Y; Wu J; Duan X
Medicine (Baltimore); 2021 Dec; 100(51):e27112. PubMed ID: 34941025
[TBL] [Abstract][Full Text] [Related]
7. Exploring the pharmacological components and effective mechanism of Mori Folium against periodontitis using network pharmacology and molecular docking.
Wu Z; Ji X; Shan C; Song J; Zhao J
Arch Oral Biol; 2022 Jul; 139():105391. PubMed ID: 35430443
[TBL] [Abstract][Full Text] [Related]
8. A double blinded placebo controlled comparative clinical trial to evaluate the effectiveness of Siddha medicines, Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy treatment in the management of symptomatic COVID 19 patients - a structured summary of a study protocol for a randomized controlled trial.
Srivastava A; Rengaraju M; Srivastava S; Narayan V; Gupta V; Upadhayay R
Trials; 2021 Feb; 22(1):130. PubMed ID: 33573696
[TBL] [Abstract][Full Text] [Related]
9. Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia.
Ye M; Luo G; Ye D; She M; Sun N; Lu YJ; Zheng J
Phytomedicine; 2021 May; 85():153401. PubMed ID: 33191068
[TBL] [Abstract][Full Text] [Related]
10. Chemical composition and therapeutic mechanism of Xuanbai Chengqi Decoction in the treatment of COVID-19 by network pharmacology, molecular docking and molecular dynamic analysis.
Fan L; Feng S; Wang T; Ding X; An X; Wang Z; Zhou K; Wang M; Zhai X; Li Y
Mol Divers; 2023 Feb; 27(1):81-102. PubMed ID: 35258759
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 induces "cytokine storm" hyperinflammatory responses in RA patients through pyroptosis.
Zheng Q; Lin R; Chen Y; Lv Q; Zhang J; Zhai J; Xu W; Wang W
Front Immunol; 2022; 13():1058884. PubMed ID: 36532040
[TBL] [Abstract][Full Text] [Related]
12. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL
Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448
[TBL] [Abstract][Full Text] [Related]
13. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis.
Wang J; Ge W; Peng X; Yuan L; He S; Fu X
Mol Divers; 2022 Apr; 26(2):1175-1190. PubMed ID: 34105049
[TBL] [Abstract][Full Text] [Related]
14. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
Zhang W; Yang Z; Zhou F; Wei Y; Ma X
Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
[TBL] [Abstract][Full Text] [Related]
15. Bioactive Components of
Yuan H; Liu L; Zhou J; Zhang T; Daily JW; Park S
J Med Food; 2022 Apr; 25(4):355-366. PubMed ID: 35438554
[TBL] [Abstract][Full Text] [Related]
16. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.
Que W; Chen M; Yang L; Zhang B; Zhao Z; Liu M; Cheng Y; Qiu H
BMC Complement Med Ther; 2021 Mar; 21(1):99. PubMed ID: 33743701
[TBL] [Abstract][Full Text] [Related]
17. Network analysis for elucidating the mechanisms of Shenfu injection in preventing and treating COVID-19 combined with heart failure.
Zhou W; Chen Z; Fang Z; Xu D
Comput Biol Med; 2022 Sep; 148():105845. PubMed ID: 35849948
[TBL] [Abstract][Full Text] [Related]
18. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
[TBL] [Abstract][Full Text] [Related]
19. Exploring the possible molecular targeting mechanism of Saussurea involucrata in the treatment of COVID-19 based on bioinformatics and network pharmacology.
Zhang D; Wang Z; Li J; Zhu J
Comput Biol Med; 2022 Jul; 146():105549. PubMed ID: 35751193
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking.
Simayi J; Nuermaimaiti M; Wumaier A; Khan N; Yusufu M; Nuer M; Maihemuti N; Bayinsang ; Adurusul K; Zhou W
Medicine (Baltimore); 2022 Jan; 101(1):e28286. PubMed ID: 35029877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]